Herpesviruses: latency and reactivation – viral strategies and host response

Eight members of the Herpesviridae family commonly infect humans, and close to 100% of the adult population is infected with at least one of these. The five that cause the most health concerns are: herpes simplex virus (HSV) type 1 and 2, Epstein–Barr virus (EBV), cytomegalovirus (CMV), and varicella zoster virus (VZV). In addition, there are human herpes virus (HHV) types 6–8. The review starts by introducing possible viral strategies in general. The particular biology and host relationship of the various human herpesviruses, including their pathology, are examined subsequently. Factors that contribute to the maintenance of latency and reactivation of viral replication are discussed. There will be special reference to how these viruses exploit and contribute to pathology in the oral cavity. Reactivation does not necessarily imply clinical symptoms, as reflected in the asymptomatic shedding of EBV and CMV from oral mucosa. The immune response and the level of viral output are both important to the consequences experienced.

[1]  B. Roizman,et al.  An inquiry into the mechanisms of herpes simplex virus latency. , 1987, Annual review of microbiology.

[2]  S. Deshmane,et al.  During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure , 1989, Journal of virology.

[3]  R. L. Thompson,et al.  Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia , 1992, Journal of virology.

[4]  D. Scadden AIDS-related malignancies. , 1998, Current opinion in oncology.

[5]  Daniel L. Feeback,et al.  Immune responses and latent herpesvirus reactivation in spaceflight. , 2001, Aviation, space, and environmental medicine.

[6]  B. Grinde,et al.  Molecular epidemiology of TTV-like mini virus in Norway , 2002, Archives of Virology.

[7]  W. Opstelten,et al.  Herpes labialis , 2003, Clinical evidence.

[8]  P. Barry,et al.  B-Virus (Cercopithecine herpesvirus 1) Infection in Humans and Macaques: Potential for Zoonotic Disease , 2003, Emerging infectious diseases.

[9]  D. C. Clark Common acute hand infections. , 2003, American family physician.

[10]  Margaret-Mary G. Wilson,et al.  Sexually transmitted diseases. , 2003, Clinics in geriatric medicine.

[11]  R. Cohrs,et al.  Clinical and molecular pathogenesis of varicella virus infection. , 2003, Viral immunology.

[12]  G. Pawelec,et al.  Is immunosenescence infectious? , 2004, Trends in immunology.

[13]  M. Lewis,et al.  Herpes simplex virus: an occupational hazard in dentistry. , 2004, International dental journal.

[14]  E. Mocarski Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system , 2004, Cellular microbiology.

[15]  A. Wald,et al.  A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.

[16]  P. Farrell,et al.  Reactivation of Epstein‐Barr virus from latency , 2005, Reviews in medical virology.

[17]  A. Kubar,et al.  Periodontitis lesions are a source of salivary cytomegalovirus and Epstein-Barr virus. , 2005, Journal of periodontal research.

[18]  J. Nicholas Review: Human Gammaherpesvirus Cytokines and Chemokine Receptors , 2005 .

[19]  J. Nicholas Human gammaherpesvirus cytokines and chemokine receptors. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[20]  P. Dřevínek,et al.  Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  Andreas Suhrbier,et al.  Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis , 2007, Journal of Virology.

[22]  E. Kozlova,et al.  Chronic herpesvirus reactivation occurs in aging , 2007, Experimental Gerontology.

[23]  G. Klein,et al.  Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions , 2007, Oncogene.

[24]  A. Vazquez,et al.  Epstein–Barr virus and virus human protein interaction maps , 2007, Proceedings of the National Academy of Sciences.

[25]  M. Diamond,et al.  Herpesvirus latency confers symbiotic protection from bacterial infection , 2007, Nature.

[26]  M. Freeman,et al.  Psychological Stress Compromises CD8+ T Cell Control of Latent Herpes Simplex Virus Type 1 Infections1 , 2007, The Journal of Immunology.

[27]  M. Hricová,et al.  Murine gammaherpesvirus 68 serum antibodies in general human population. , 2007, Acta virologica.

[28]  O. Cinek,et al.  Longitudinal observation of parechovirus in stool samples from Norwegian infants , 2008, Journal of medical virology.

[29]  K. Beiske,et al.  Human cytomegalovirus and Epstein–Barr virus in apical and marginal periodontitis: A role in pathology? , 2008, Journal of medical virology.

[30]  I. Olsen,et al.  Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[31]  L. Cooper,et al.  Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus , 2008, PloS one.

[32]  Y. Chida,et al.  Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies , 2009, Brain, Behavior, and Immunity.

[33]  B. Cullen,et al.  Viruses, microRNAs, and host interactions. , 2010, Annual review of microbiology.

[34]  G. Pawelec,et al.  Senescence of the human immune system. , 2010, Journal of comparative pathology.

[35]  A. Froment,et al.  Frequent and Recent Human Acquisition of Simian Foamy Viruses Through Apes' Bites in Central Africa , 2011, PLoS pathogens.

[36]  H. Agut,et al.  Herpes simplex encephalitis : from virus to therapy. , 2011, Infectious disorders drug targets.

[37]  D. Lindemann,et al.  Foamy Virus Biology and Its Application for Vector Development , 2011, Viruses.

[38]  H. Balfour,et al.  Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections , 2011, Clinical Microbiology Reviews.

[39]  R. Hendricks,et al.  CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation , 2011, Journal of NeuroVirology.

[40]  Marco Y. Hein,et al.  Decoding Human Cytomegalovirus , 2012, Science.

[41]  I. Mohr,et al.  A cultured affair: HSV latency and reactivation in neurons. , 2012, Trends in microbiology.

[42]  Asim V. Farooq,et al.  Herpes simplex epithelial and stromal keratitis: an epidemiologic update. , 2012, Survey of ophthalmology.

[43]  R. Beigi Sexually Transmitted Diseases: Beigi/Sexually Transmitted Diseases , 2012 .

[44]  I. Mohr,et al.  Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. , 2012, Genes & development.

[45]  W. Hammerschmidt,et al.  The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination , 2012, PLoS pathogens.

[46]  M. Ryder,et al.  Periodontal disease in HIV/AIDS. , 2012, Periodontology 2000.

[47]  A. Osterhaus,et al.  Longitudinal study on oral shedding of herpes simplex virus 1 and varicella‐zoster virus in individuals infected with HIV , 2013, Journal of medical virology.

[48]  G. Rimmelzwaan,et al.  Clearance of influenza virus infections by T cells: risk of collateral damage? , 2013, Current opinion in virology.

[49]  C. Evans,et al.  Management of herpesvirus infections. , 2013, International journal of antimicrobial agents.

[50]  M. Forsgren,et al.  Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  D. Shukla,et al.  Recent advances in vaccine development for herpes simplex virus types I and II , 2013, Human vaccines & immunotherapeutics.

[52]  J. Fishman Overview: Cytomegalovirus and the Herpesviruses in Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[53]  J. Nelson,et al.  Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis. , 2013, Current opinion in virology.